The Aryl Hydrocarbon Receptor is a Repressor of Inflammation-associated Colorectal Tumorigenesis in Mouse
Open accessThe DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: To determine the role of the aryl hydrocarbon receptor (AHR) in colitis-associated colorectal tumorigenesis. BACKGROUND: Colorectal cancer (CRC) is the third most commonly diagnosed cancer in United States. Chronic intestinal inflammation increases the risk for the development of CRC. We investigated the involvement of AHR, a ligand-activated transcriptional regulator, in colitis-associated colorectal tumorigenesis. METHODS: We used a mouse model of colitis-associated colorectal tumorigenesis that employs treatment with azoxymethane and dextran sodium sulfate. We examined the role of AHR using both an Ahr-deletion mouse model (Ahr) and treatment with the AHR pro-agonist indole-3-carbinol (I3C). Incidence, multiplicity, and location of tumors were visually counted. Tumors were defined as neoplasms. Intestinal inflammation was assessed by quantitative PCR for proinflammatory markers and colon length. Data were evaluated and compared using GraphPad Prism software (version 6, La Jolla, CA). RESULTS: Tumor incidence was increased 32% in Ahr null mice and tumor multiplicity was approximately increased 3-fold compared with wild-type mice (2.4 vs 7; P < 0.05). Furthermore, tumor multiplicity was reduced 92% by treatment of I3C in wild-type mice, whereas the suppressor effect of I3C was not observed in Ahr null mice (P < 0.05). CONCLUSIONS: We found that AHR plays a protective role in colitis-associated colorectal tumorigenesis. This conclusion is based on the observations that Ahr null mice showed increased number of colorectal tumors, and mice treated with I3C exhibited fewer tumors. This study supports the use of AHR agonists such as I3C as a chemopreventive therapy for IBD-associated CRC in human patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Modulation of oxidative stress as an anticancer strategy
Gorrini, C., Harris, I. S., & Mak, T. W. (2013) · Nature Reviews Drug Discovery · doi:10.1038/nrd4002 · Cited by 3,579
The Aryl Hydrocarbon Receptor Complex
Hankinson, O. (1995) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pa.35.040195.001515 · Cited by 1,649 · cited 2×
“The AHR is a member of the basic helixloop-helix/Per-Arnt-Sim (PAS) superfamily of transcription factors and has been identified as a mediator of the toxic effects of environmental pollutants such as 2,3,7,8-tetrachlorodibenzo-p-dioxin and benzo(a)pyrene.(9,10) Upon ligand binding, AHR translocates into the nucleus wh…”
BackgroundAH RECEPTOR SIGNALING PATHWAYS
Schmidt, J. V., & Bradfield, C. A. (1996) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.12.1.55 · Cited by 899 · cited 2×
“The AHR is a member of the basic helixloop-helix/Per-Arnt-Sim (PAS) superfamily of transcription factors and has been identified as a mediator of the toxic effects of environmental pollutants such as 2,3,7,8-tetrachlorodibenzo-p-dioxin and benzo(a)pyrene.(9,10) Upon ligand binding, AHR translocates into the nucleus wh…”
BackgroundSelf-citationLee, J. S., Cella, M., McDonald, K. G., Garlanda, C., Kennedy, G. D., Nukaya, M., Mantovani, A., Kopan, R., Bradfield, C. A., Newberry, R. D., et al. (2012) · Nature Immunology · doi:10.1038/ni.2187 · Cited by 777 · cited 2×
“In the past several years, experiments using Ahr deletion mouse models have revealed that AHR is a fundamental player in mediating intestinal inflammation through regulation of both intraepithelial lymphocytes (IELs) and innate lymphoid cells (ILCs).(7,8) The relationship between AHR and intestinal immunity, and the i…”
BackgroundSelf-citationLahvis, G. P., Lindell, S. L., Thomas, R. S., McCuskey, R. S., Murphy, C., Glover, E., Bentz, M., Southard, J., & Bradfield, C. A. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.190256997 · Cited by 377
Self-citation
Cited by
Metidji, A., Omenetti, S., Crotta, S., Li, Y., Nye, E., Ross, E., Li, V., Maradana, M. R., Schiering, C., & Stockinger, B. (2018) · Immunity · doi:10.1016/j.immuni.2018.07.010 · Cited by 402
“The progression from inflammation to tumorigenesis is well established (Sch€ afer and Werner, 2008) and our mice readily developed mixed colon adenomas/adenocarcinomas in the standard AOM/DSS model in line with previous data in global Ahr / mice (Dı́az-Dı́az et al., 2016) or even with the mutagen AOM alone.”
BackgroundResultAHR in the intestinal microenvironment: safeguarding barrier function
Stockinger, B., Shah, K., & Wincent, E. (2021) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-021-00430-8 · Cited by 403
Tryptophan (Trp) modulates gut homeostasis via aryl hydrocarbon receptor (AhR)
Sun, M., Ma, N., He, T., Johnston, L. J., & Ma, X. (2020) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2019.1598334 · Cited by 331
In vitro toxicity and in silico docking analysis of two novel selective AH-receptor modulators
Mahiout, S., Tagliabue, S. G., Nasri, A., Omoruyi, I. M., Pettersson, L., Bonati, L., & Pohjanvirta, R. (2018) · Toxicology in Vitro · doi:10.1016/j.tiv.2018.06.010 · Cited by 19
Rodent Genetic Models of Ah Receptor Signaling
Wilson, R. H., & Bradfield, C. A. (2021) · Drug Metabolism Reviews · doi:10.1080/03602532.2021.1955916 · Cited by 16
Self-citation
Metadata
- Authors
- Díaz-Díaz, C. J., Ronnekleiv-Kelly, S. M., Nukaya, M., Geiger, P. G., Balbo, S., Dator, R., Megna, B. W., Carney, P. R., Bradfield, C. A., & Kennedy, G. D.
- Venue
- Annals of Surgery
- Published
- 2016-09
- Volume
- 264
- Issue
- 3
- Pages
- 429-436
- ISSN
- 0003-4932 (ISSN-L)
- OpenAlex
- W2500289812
- Cited by
- 96
- References
- 5
- FWCI
- 4.29
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The Aryl Hydrocarbon Receptor is a Repressor of Inflammation-associated Colorectal Tumorigenesis in Mouse. https://app.cochat.ai/papers/10.1097/sla.0000000000001874
- The paper
- Díaz-Díaz, C. J., Ronnekleiv-Kelly, S. M., Nukaya, M., Geiger, P. G., Balbo, S., Dator, R., Megna, B. W., Carney, P. R., Bradfield, C. A., & Kennedy, G. D. (2016). The Aryl Hydrocarbon Receptor is a Repressor of Inflammation-associated Colorectal Tumorigenesis in Mouse. Annals of Surgery. https://doi.org/10.1097/sla.0000000000001874
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.